Literature DB >> 12732330

Peptides derived from the two regulatory domains of p53 are recognized by two p53-activating antibodies.

Jean-Michel Portefaix1, Maguy Del Rio, Claude Granier, Françoise Roquet, Bernard Pau, Isabelle Navarro-Teulon.   

Abstract

The C-terminus of the transcription factor p53 seems to play an important role by controlling the specific DNA-binding activity, which is directly associated with sensing damaged DNA. Another region located in the N-terminus of the protein has also been shown to regulate the DNA-binding activity of the protein. This activity can be promoted by peptides derived from these two negative regulatory regions or by binding of antibodies directed against the C-terminus of the p53 protein. Using both phage display peptide and multiple peptide synthesis technologies, we demonstrated that mAbs HR231 and Pab421, two p53-activating antibodies, recognize peptides derived from the C-terminus of p53, as previously described, but also peptides from the N-terminus of the protein, suggesting that these peptides are part of a conformational epitope. Furthermore, the sequences of these peptides are located in the two negative regulatory regions identified on the p53 protein, which is consistent with the biological activity of mAbs HR231 and Pab421.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732330     DOI: 10.1016/s0196-9781(03)00047-0

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  1 in total

1.  Effects of dendritic cells transfected with full-length wild-type p53 and stimulated by gastric cancer lysates on immune response.

Authors:  Hua-Wen Sun; Qi-Bing Tang; Yong-Jun Cheng; Sheng-Qian Zou
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.